Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Evotec has formed a research agreement with Harvard University and the Howard Hughes Medical Institute (HHMI) to discover and develop new treatments for diabetes.
Subscribe to our email newsletter
The initial aim of the collaboration is to pursue a comprehensive and systematic approach to identify and develop physiological mechanisms and targets that regulate beta cell replication.
Evotec CSO Cord Dohrmann said they are enthusiastic about exploring new mechanisms that have the potential to restore beta cell function and produce first-in-class therapeutics for the treatment of diabetes in collaboration with Harvard and HHMI.